Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Fen1 mutations result in autoimmunity, chronic inflammation and cancers.

Authors: Zheng, L  Dai, H  Zhou, M  Li, M  Singh, P  Qiu, J  Tsark, W  Huang, Q  Kernstine, K  Zhang, X  Lin, D  Shen, B 
Citation: Zheng L, etal., Nat Med. 2007 Jul;13(7):812-9. Epub 2007 Jun 24.
Pubmed: (View Article at PubMed) PMID:17589521
DOI: Full-text: DOI:10.1038/nm1599

Functional deficiency of the FEN1 gene has been suggested to cause genomic instability and cancer predisposition. We have identified a group of FEN1 mutations in human cancer specimens. Most of these mutations abrogated two of three nuclease activities of flap endonuclease 1 (FEN1). To demonstrate the etiological significance of these somatic mutations, we inbred a mouse line harboring the E160D mutation representing mutations identified in human cancers. Selective elimination of nuclease activities led to frequent spontaneous mutations and accumulation of incompletely digested DNA fragments in apoptotic cells. The mutant mice were predisposed to autoimmunity, chronic inflammation and cancers. The mutator phenotype results in the initiation of cancer, whereas chronic inflammation promotes the cancer progression. The current work exemplifies the approach of studying the mechanisms of individual polymorphisms and somatic mutations in cancer development, and may serve as a reference in developing new therapeutic regimens through the suppression of inflammatory responses.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 6484213
Created: 2012-06-13
Species: All species
Last Modified: 2012-06-13
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.